Enfusion Inc’s filing revealed that its General Counsel Campobasso Matthew unloaded Company’s shares for reported $943.0 on Feb 29 ’24. In the deal valued at $8.73 per share,108 shares were sold. As a result of this transaction, Campobasso Matthew now holds 30,840 shares worth roughly $0.29 million.
Then, Gutowski Valeria sold 27 shares, generating $236 in total proceeds. Upon selling the shares at $8.73, the Chief Accounting Officer now owns 17,570 shares.
Before that, Somers Deirdre sold 1,770 shares. Enfusion Inc shares valued at $15,310 were divested by the Director at a price of $8.65 per share. As a result of the transaction, Somers Deirdre now holds 34,471 shares, worth roughly $0.32 million.
Goldman downgraded its Enfusion Inc [ENFN] rating to a Sell from a a Neutral in a research note published on February 28, 2024; the price target was decreased to $8 from $9. A number of analysts have revised their coverage, including JP Morgan’s analysts, who decreased its forecast for the stock in late January from “a Neutral” to “an Underweight”. UBS began covering ENFN with “Neutral” recommendation on November 07, 2023. Piper Sandler started covering the stock on April 03, 2023. It rated ENFN as “a Neutral”.
Price Performance Review of ENFN
On Tuesday, Enfusion Inc [NYSE:ENFN] saw its stock jump 1.20% to $9.27. Over the last five days, the stock has lost -4.04%. Enfusion Inc shares have fallen nearly -4.43% since the year began. Nevertheless, the stocks have fallen -3.94% over the past one year. While a 52-week high of $11.56 was reached on 04/09/24, a 52-week low of $7.37 was recorded on 01/30/24. SMA at 50 days reached $8.99, while 200 days put it at $9.24. A total of 0.37 million shares were traded, compared to the trading of 0.37 million shares in the previous session.
Levels Of Support And Resistance For ENFN Stock
The 24-hour chart illustrates a support level at 9.10, which if violated will result in even more drops to 8.94. On the upside, there is a resistance level at 9.37. A further resistance level may holdings at 9.48. The Relative Strength Index (RSI) on the 14-day chart is 50.89, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.04, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 66.22%. Stochastics %K at 42.82% indicates the stock is a holding.
The most recent change occurred on March 15, 2023 when JP Morgan began covering the stock and recommended ‘”a Neutral”‘ rating along with a $12 price target.
